Drug Approval | October 06, 2025
With global certification in place, the Ambernath site expands Supriya’s footprint beyond APIs into high-margin formulations
The expansion, supported by a significant UK government grant, includes a new lipid system synthesis facility and enhanced R&D capabilities
Ultra-high purity surfactant for biologics and parenteral drug formulations
The inspection concluded with zero form 483 observations
This marks the first of four new U.S. manufacturing sites that Lilly plans to announce this year
Brenntag will supply Food & Nutrition customers in the United States and Canada with Lallemand’s renowned Nutrilife baking enzyme range
Nu Nutridac is a nutritional replenisher for neurodegenerative and anxiety-related disorders
New unit boosts innovation in liposomal delivery technologies with 8,500 MT capacity and export-ready production
Subscribe To Our Newsletter & Stay Updated
